Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicountry, Multicenter, Secondary Data Collection, Retrospective Observational Study to Describe the Characteristics and Management of Hepatocellular Carcinoma (HCC) Among Adults in the Middle East Region

NCT07650773 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07650773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07650773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicountry, Multicenter, Secondary Data Collection, Retrospective Observational Study to Describe the Characteristics and Management of Hepatocellular Carcinoma (HCC) Among Adults in the Middle East Region
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
July 14, 2026
Completion date
November 30, 2027
Enrollment
4,000 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma